Law Practice
Jul. 18, 2012
Orrick helps with pharmaceutical sale
A team of attorneys from Orrick, Herrington & Sutcliffe LLP's San Francisco office advised New Jersey-based Par Pharmaceutical Companies Inc. in its $1.9 billion acquisition by a fund affiliated with TPG Capital.
Daily Journal Staff Writer
Orrick, Herrington & Sutcliffe LLP represented New Jersey-based Par Pharmaceutical Companies Inc. - one of the largest U.S. generic drug companies - in its planned $1.9 billion acquisition by a fund affiliated with private equity firm TPG Capital.
New York corporate partner R. King Milling led a team of Orrick attorneys, including San Francisco mergers and acquisitions and private equity partne...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In